Former Pfizer Inc. lawyer Louisa Daniels, who provided legal support for the biopharma giant’s COVID-19 vaccine program, has joined biotech startup Recursion Pharmaceuticals as its general counsel and chief legal officer.

Daniels, who has extensive in-house experience in the biopharma sector, headed a clinical development legal team that provided key legal support for Pfizer’s “Operation Light Speed” COVID-19 vaccine program. 

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]